PTC (PTC) last closed at US$144.03 after a period that included mixed return patterns over the past year. Investors now have fresh numbers on revenue, earnings, and valuation to reassess the software specialist.
Recent trading has been choppy for PTC, with the share price slipping 1.67% over the last day but recording a 15.19% 90 day share price return and a 2.13% 30 day share price return. Over a longer window, momentum looks weaker, with the year to date share price return down 15.33% and the 1 year total shareholder return down 29.74%. However, the 5 year total shareholder return of 22.12% shows a very different experience for investors who have held through the cycles.
Look beyond PTC's recent swings and compare similar software peers by reviewing our curated list of 19 high quality undiscovered gems for investors interested in conducting patient research.
The mixed price pattern around US$144.03 leaves a basic question hanging. Are you seeing a reset in how investors feel about PTC, or a clearer reflection of what the business is worth today?
Against PTC's last close at $144.03, the most followed narrative anchors fair value at $173.35, so the current quote sits well below that reference point while still reflecting a business with meaningful earnings and cash flow assumptions baked in.
The shift in commercial terms from negotiated renewals with 1% to 2% realized annual price to CPP contracts with 3% to 4% embedded yearly uplift, combined with token based and overage pricing for AI features such as ServiceMax AI, is intended to support structurally higher pricing and could lift revenue growth and earnings over time as more of the base converts.
See why 21 investors see PTC as 17% undervalued.
Result: Fair Value of $173.35 (UNDERVALUED)
Still, parts of the PTC story can cut the other way if ServiceMax churn stays elevated or if investors assign a lower P/E multiple than analysts assume.
Find out about the key risks to this PTC narrative.
Mixed signals on PTC can feel uncomfortable, so move quickly from headlines to hard evidence and weigh both the potential benefits and the red flags in the 4 key rewards and 1 important warning sign.
If the PTC picture still feels incomplete, you can broaden your watchlist with a few targeted stock ideas that match how you like to balance opportunity and risk.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com